Blood flow stimulation and reduction of sensory neurotoxicities in cytostatic-induced polyneuropathy
due to repeatable short-treatment periods
(even through shoes)
MAGCELL® ARTHRO significantly improves general symptoms (WOMAC total score) and individual scores for pain, stiffness and daily activity in osteoarthritis (ARC criteria II and III). The therapy can be applied several times daily as a complementary treatment without side effects and may thus help to reduce intake of pain medication.
In a randomised controlled study on the effect of MAGCELL® ARTHRO for knee arthritis with osteoarthritis level 2.8±0.8 (American College of Rheumatology criteria) at the primary clinical end point (WOMAC total score) median increase of 0.7 P (non-significant) was recorded in the placebo group between T0 and T1 (18 days), yet in the MAGCELL®-group a significant local decrease of 21.8 P. During the study no undesirable incidents or side effects occurred related to therapy.
Through a patent-registered, innovative procedure, MAGCELL® ARTHRO is able to create exceptionally strong pulsating magnetic fields of up to 100 mT (1000 gauss) with selective frequency ranges despite its small size. Time-variable magnetic fields can function as transfer media for electric fields. Providing that – like MAGCELL® ARTHRO – the field force is sufficiently high, electro-magnetic fields can be induced in the tissue beyond the internationally recognised threshold for biological effectiveness. Through the possibility of direct application and the resulting close distance of the magnetic field to the application area, MAGCELL® ARTHRO also ensures minimum loss of magnetic field strength, transporting it deep into the tissue layers (electrode-free electrotherapy). Its battery operation and thus constant readiness enables the execution of a therapy programme through repeated short treatments in contrast to treatments previously only offered in doctor’s surgeries.
MAGCELL® ARTHRO is ideal for painful hip, knee and jaw joint arthritis, Hallux rigidus and valgus and a range of other arthritic conditions. Clinical studies on the complementary use of MAGCELL® ARTHRO for acute knee arthritis (1,2) have shown that amongst others, the following clinical effects can be achieved:
Magnetic field therapy is available in a range of types and appearances. Various forms of therapy do not have sufficient scientific proof of their effectiveness. The MAGCELL® ARTHRO medical product cannot be compared with ‘pulsating signal therapy (PST)’, ‘MultiBioSignal Therapy (MBST)’, ‘Nuclear Magnetic Resonance Therapy’, ‘TENS' or other transmission forms such as magnetic field mats or coils.
MAGCELL® ARTHRO works with therapy parameters investigated in empirical and clinical research. There are no known side effects or intolerance associated with the use of MAGCELL® ARTHRO. Based on a large amount of patient feedback, regular therapy may enable reductions in the dosage of medication, such as non-steroidal anti-rheumatic agents.
1 Hitrov N, Portnov V (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3:25-27.
2 Wuschech H., von Hehn U., Mikus E., Funk R.H. (2015): Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study. Bioelectromagnetics 36(8), 576–585.
The WOMAC individual scores for pain, stiffness and daily activity also resulted in significant local improvements in the MAGCELL®-group compared to a slight median increase (non-significant) in the placebo group. A highly significant result (p < 0.001) in favour of the MAGCELL®-group was recorded for the individual parameter pain reduction compared to the placebo in the difference between the beginning and end of treatment.
Funk H.W., Knels L., Augstein A., Marquetant R., Dertinger H.F. (2014): Potent Stimulation of Blood Flow of Volunteers after Local Short-Term Treatment with Low-Frequency Magnetic Fields from a Novel Device. Evidence-Based Complementary and Alternative Medicine 2014. Article ID 543564, 9 pages. http://dx.doi.org/10.1155/2014/543564.
Geiger G., Mikus E., Dertinger H., Rick O. (2015): Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: A phase II pilot study. Bioelectromagnetics 36(3): 251-254. doi: 10.1002/bem.21897.
Hitrov N.A., Portnov V.V. (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3, 25-27.
Leoci R., Aiudi G., Silvestre F., Lissner E., Lacalandra G.M. (2014): Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Traetment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model. The Prostate 74: 1132-1141.
Tenuta M, Tarsitano MG, Mazzotta P, Lucchini L, Sesti F, Fattorini G, Pozza C, Olivieri V, Naro F, Gianfrilli D, Lenzi A, Isidori AM, Pofi R. Therapeutic Use of Pulsed Electromagnetic Field Therapy Reduces ProstateVolume and Lower UrinaryTract Symptoms in Benign Prostatic Hyperplasia. Andrology. 2020 Feb 23. doi: 10.1111/andr.12775. [Epub ahead of print] PubMed PMID: 32090492.
Reimschüssel A., Bodenburg P. (2009): Niederfrequente elektromagnetische Felder. Erfolgreich in der Therapie der Myoarthritis des Kiefergelenkes. Die Naturheilkunde 5, 28.
Rick O., von Hehn U., Mikus E., Dertinger H., Geiger G. (2017): Magnetic Field Therapy in Patients With Cytostatics-Induced Polyneuropathy: A Prospective Randomized Placebo-Controlled Phase-III Study. Bioelectromagnetics 38(2): 85-94:. doi: 10.1002/bem.22005.
Wuschech H., von Hehn U., Mikus E., Funk R.H. (2015): Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study. Bioelectromagnetics 36(8), 576–585.